| Not Yet Recruiting | Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy Leprosy | Phase 1 | 2025-01-02 |
| Unknown | Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients Leprosy | Phase 1 / Phase 2 | 2024-02-01 |
| Unknown | Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Cov Vaccine-induced Thrombotic Thrombocytopenia Syndrome, Guillain-Barre Syndrome, Acute Disseminated Encephalomyelitis | — | 2022-10-04 |
| Unknown | Effectiveness of Vaccination Against COVID-19 in Brazil: Case-Control Study COVID-19 Vaccines | — | 2022-02-07 |
| Unknown | Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccin Measles Vaccine | — | 2022-01-04 |
| Unknown | Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine COVID-19 | Phase 4 | 2021-11-09 |
| Unknown | Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Dose COVID-19 | Phase 4 | 2021-07-20 |
| Completed | Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed Measles | — | 2020-04-06 |
| Unknown | Duration of Immunity 10 Years After a Dose-response Study With Yellow Fever Vaccine - Complementary Study Yellow Fever Vaccine | — | 2019-04-08 |
| Completed | Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Ru Rubella, Measles | Phase 2 / Phase 3 | 2018-11-20 |
| Unknown | Conjugate Vaccine Against Meningococcus C a Brazilian Project Serogroup C Meningococcal Meningitis | Phase 2 / Phase 3 | 2018-09-25 |
| Completed | Usability Study of a Self-test Prototype for Human Immunodeficiency Virus (HIV) Screening Mass Screening | — | 2018-06-19 |
| Completed | Clinical Study of Immunity Duration of Yellow Fever Vaccine in Military Yellow Fever Vaccine | — | 2017-03-27 |
| Unknown | Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis Drug-Related Side Effects and Adverse Reactions | — | 2017-01-30 |
| Unknown | Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subje Foot Ulcer, Diabetic, Epidermal Growth Factor | Phase 3 | 2017-01-01 |
| Active Not Recruiting | Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study) Yellow Fever Vaccine, Immunity | Phase 4 | 2016-07-01 |
| Unknown | Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa Red-Cell Aplasia, Pure, Renal Insufficiency, Chronic | Phase 4 | 2015-11-01 |
| Completed | Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella Rubella, Measles | Phase 1 | 2015-09-01 |
| Unknown | Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children Human Immunodeficiency Virus Transmission, Human Immunodeficiency Virus, Diagnoses, Syndromes, and Conditions | — | 2015-03-12 |
| Completed | Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced Measles, Mumps, Rubella | Phase 3 | 2015-02-01 |
| Completed | Immunity After Two Doses of Yellow Fever Vaccine Yellow Fever | — | 2014-05-01 |
| Completed | Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinh Meningitis, Meningococcal, Serogroup C | Phase 1 | 2014-05-01 |
| Completed | Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presenta Measles, Mumps, Rubella | Phase 4 | 2012-10-01 |
| Unknown | BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic H Chronic Hepatitis C | Phase 2 / Phase 3 | 2012-01-01 |
| Completed | Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers Chronic Viral Hepatitis C | Phase 1 | 2010-10-01 |
| Completed | Interferon α 2b Pharmacovigilance Study Hepatitis C, Chronic | Phase 4 | 2009-05-01 |
| Completed | Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella) Mumps, Rubella, Measles | — | 2008-05-01 |